Stockigt JR - Search Results

1

Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.

Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Välimäki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP. Boyden LM, et al. Among authors: stockigt jr. Nature. 2012 Jan 22;482(7383):98-102. doi: 10.1038/nature10814. Nature. 2012. PMID: 22266938 Free PMC article.

2

The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.

Jung C, Alford FP, Topliss DJ, Burgess JR, Long F, Gome JJ, Stockigt JR, Inder WJ. Jung C, et al. Among authors: stockigt jr. Clin Endocrinol (Oxf). 2010 Jul;73(1):78-84. doi: 10.1111/j.1365-2265.2009.03756.x. Epub 2009 Dec 18. Clin Endocrinol (Oxf). 2010. PMID: 20039897

3

Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine.

Stockigt JR, Lim CF. Stockigt JR, et al. Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):753-67. doi: 10.1016/j.beem.2009.06.004. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19942151 Review.

4

Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.

Wong R, Topliss DJ, Bach LA, Hamblin PS, Kalff V, Long F, Stockigt JR. Wong R, et al. Among authors: stockigt jr. Intern Med J. 2009 Mar;39(3):156-63. doi: 10.1111/j.1445-5994.2008.01735.x. Intern Med J. 2009. PMID: 19383064

5

Obstetric implications of current Australian product information for thyroid-related medications.

Stockigt JR. Stockigt JR. Aust N Z J Obstet Gynaecol. 2009 Feb;49(1):64-6. doi: 10.1111/j.1479-828X.2008.00944.x. Aust N Z J Obstet Gynaecol. 2009. PMID: 19281582 No abstract available.

6

The quality of medication information in Australia: the need for more clinical expertise and accountability.

Stockigt JR. Stockigt JR. Med J Aust. 2009 Feb 2;190(3):110-1. doi: 10.5694/j.1326-5377.2009.tb02306.x. Med J Aust. 2009. PMID: 19203304 No abstract available.

7

Comparison of consumer medication information in the United States, Europe, and Australia.

Stockigt JR. Stockigt JR. J Am Pharm Assoc (2003). 2008 May-Jun;48(3):326; author reply 326, 331. doi: 10.1331/JAPhA.2008.08006. J Am Pharm Assoc (2003). 2008. PMID: 18595818 No abstract available.

8

Misleading advertising of PI-based drug information?

Stockigt JR. Stockigt JR. Med J Aust. 2008 Jun 2;188(11):679-80; discussion 680. doi: 10.5694/j.1326-5377.2008.tb01913.x. Med J Aust. 2008. PMID: 18513184 No abstract available.

9

The National Prescribing Service should lead.

Stockigt JR. Stockigt JR. Med J Aust. 2007 May 7;186(9):484. doi: 10.5694/j.1326-5377.2007.tb01009.x. Med J Aust. 2007. PMID: 17484717 No abstract available.

10

Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications.

Stockigt JR. Stockigt JR. Med J Aust. 2007 Jan 15;186(2):76-9. doi: 10.5694/j.1326-5377.2007.tb00805.x. Med J Aust. 2007. PMID: 17223768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page